| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| imipramine | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | alpha-1d adrenergic receptor | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank , DGIDB | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.12 | approved | antagonist |
| imipramine | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | muscarinic acetylcholine receptor m4 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | muscarinic acetylcholine receptor m5 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | d(1) dopamine receptor | small molecule | NA | drugbank , DGIDB | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.06 | approved | binder |
| imipramine | dopamine d2 receptor | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | binder |
| imipramine | d(1) dopamine receptor | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | binder |
| imipramine | histamine h1 receptor | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | activator |
| imipramine | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist,binder |
| imipramine | 5-hydroxytryptamine receptor 6 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | binder |
| imipramine | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
| imipramine | potassium voltage-gated channel subfamily d member 2 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
| imipramine | potassium voltage-gated channel subfamily d member 3 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
| imipramine | potassium voltage-gated channel subfamily h member 1 | small molecule | NA | drugbank , DGIDB | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.82 | approved | blocker |
| imipramine | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
| imipramine | alpha-1-acid glycoprotein 2 | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | unknown |
| imipramine | norepinephrine transporter | NA | Successful target | TTD , DGIDB | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.8 | approved | inhibitor |
| imipramine | sodium-dependent noradrenaline transporter | small molecule | NA | drugbank , DGIDB | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.8 | approved | inhibitor |
| imipramine | norepinephrine transporter | NA | Successful target | TTD , DGIDB | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.8 | approved | unknown |
| imipramine | sodium-dependent dopamine transporter | small molecule | NA | drugbank | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
| imipramine | sodium-dependent serotonin transporter | small molecule | NA | drugbank , DGIDB | Urinary Incontinence[MeSHID:D014549] Disease Management[MeSHID:D019468] Stress Disorders Traumatic Acute[MeSHID:D040701] Enuresis[MeSHID:D004775] Post-Traumatic Stress Disorder[MeSHID:D013313] Panic Disorder[MeSHID:D016584] Off-Label Use[MeSHID:D056687] Depressive Symptoms[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Term Birth[MeSHID:D047929] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Attention deficit hyperactivity disorder[MeSHID:D001289] Postherpetic neuralgia[MeSHID:D051474] Bedwetting[MeSHID:D053206] Bulimia Nervosa[MeSHID:D052018] Neoplasm Metastasis[MeSHID:D009362] Diabetic Neuralgia[MeSHID:D003929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.83 | approved | inhibitor |
| click here to return to the previous page | ||||||||